Request for Covid-19 Impact Assessment of this Report
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of PCSK9 Inhibitors in these regions, from 2013 to 2025 (forecast).
United States PCSK9 Inhibitors market competition by top manufacturers/players, with PCSK9 Inhibitors sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Amgen
Eli Lilly
Sanofi
Pfizer
Novartis
Roche
Merck
Alnylam
AstraZeneca
Affiris
BMS
Ionis Pharmaceuticals
Cyon Therapeutics
Daiichi Sankyo
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Epatha?Evolocumab?
Praluent?Alirocumab?
Bococizumab
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Clinical Application
Drug Development
Other
If you have any special requirements, please let us know and we will offer you the report as you want.
United States PCSK9 Inhibitors Market Report 2018
1 PCSK9 Inhibitors Overview
1.1 Product Overview and Scope of PCSK9 Inhibitors
1.2 Classification of PCSK9 Inhibitors by Product Category
1.2.1 United States PCSK9 Inhibitors Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States PCSK9 Inhibitors Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Epatha?Evolocumab?
1.2.4 Praluent?Alirocumab?
1.2.5 Bococizumab
1.2.6 Others
1.3 United States PCSK9 Inhibitors Market by Application/End Users
1.3.1 United States PCSK9 Inhibitors Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Clinical Application
1.3.3 Drug Development
1.3.4 Other
1.4 United States PCSK9 Inhibitors Market by Region
1.4.1 United States PCSK9 Inhibitors Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West PCSK9 Inhibitors Status and Prospect (2013-2025)
1.4.3 Southwest PCSK9 Inhibitors Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic PCSK9 Inhibitors Status and Prospect (2013-2025)
1.4.5 New England PCSK9 Inhibitors Status and Prospect (2013-2025)
1.4.6 The South PCSK9 Inhibitors Status and Prospect (2013-2025)
1.4.7 The Midwest PCSK9 Inhibitors Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of PCSK9 Inhibitors (2013-2025)
1.5.1 United States PCSK9 Inhibitors Sales and Growth Rate (2013-2025)
1.5.2 United States PCSK9 Inhibitors Revenue and Growth Rate (2013-2025)
2 United States PCSK9 Inhibitors Market Competition by Players/Suppliers
2.1 United States PCSK9 Inhibitors Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States PCSK9 Inhibitors Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States PCSK9 Inhibitors Average Price by Players/Suppliers (2013-2018)
2.4 United States PCSK9 Inhibitors Market Competitive Situation and Trends
2.4.1 United States PCSK9 Inhibitors Market Concentration Rate
2.4.2 United States PCSK9 Inhibitors Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers PCSK9 Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
3 United States PCSK9 Inhibitors Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States PCSK9 Inhibitors Sales and Market Share by Region (2013-2018)
3.2 United States PCSK9 Inhibitors Revenue and Market Share by Region (2013-2018)
3.3 United States PCSK9 Inhibitors Price by Region (2013-2018)
4 United States PCSK9 Inhibitors Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States PCSK9 Inhibitors Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States PCSK9 Inhibitors Revenue and Market Share by Type (2013-2018)
4.3 United States PCSK9 Inhibitors Price by Type (2013-2018)
4.4 United States PCSK9 Inhibitors Sales Growth Rate by Type (2013-2018)
5 United States PCSK9 Inhibitors Sales (Volume) by Application (2013-2018)
5.1 United States PCSK9 Inhibitors Sales and Market Share by Application (2013-2018)
5.2 United States PCSK9 Inhibitors Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States PCSK9 Inhibitors Players/Suppliers Profiles and Sales Data
6.1 Amgen
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 PCSK9 Inhibitors Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Amgen PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Eli Lilly
6.2.2 PCSK9 Inhibitors Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Eli Lilly PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Sanofi
6.3.2 PCSK9 Inhibitors Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Sanofi PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.2 PCSK9 Inhibitors Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Novartis
6.5.2 PCSK9 Inhibitors Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Novartis PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Roche
6.6.2 PCSK9 Inhibitors Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Roche PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Merck
6.7.2 PCSK9 Inhibitors Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Merck PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Alnylam
6.8.2 PCSK9 Inhibitors Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Alnylam PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 AstraZeneca
6.9.2 PCSK9 Inhibitors Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 AstraZeneca PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Affiris
6.10.2 PCSK9 Inhibitors Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Affiris PCSK9 Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 BMS
6.12 Ionis Pharmaceuticals
6.13 Cyon Therapeutics
6.14 Daiichi Sankyo
7 PCSK9 Inhibitors Manufacturing Cost Analysis
7.1 PCSK9 Inhibitors Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of PCSK9 Inhibitors
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 PCSK9 Inhibitors Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of PCSK9 Inhibitors Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States PCSK9 Inhibitors Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States PCSK9 Inhibitors Sales Volume, Revenue Forecast (2018-2025)
11.2 United States PCSK9 Inhibitors Sales Volume Forecast by Type (2018-2025)
11.3 United States PCSK9 Inhibitors Sales Volume Forecast by Application (2018-2025)
11.4 United States PCSK9 Inhibitors Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Figure Product Picture of PCSK9 Inhibitors
Figure United States PCSK9 Inhibitors Market Size (K Units) by Type (2013-2025)
Figure United States PCSK9 Inhibitors Sales Volume Market Share by Type (Product Category) in 2017
Figure Epatha?Evolocumab? Product Picture
Figure Praluent?Alirocumab? Product Picture
Figure Bococizumab Product Picture
Figure Others Product Picture
Figure United States PCSK9 Inhibitors Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of PCSK9 Inhibitors by Application in 2017
Figure Clinical Application Examples
Table Key Downstream Customer in Clinical Application
Figure Drug Development Examples
Table Key Downstream Customer in Drug Development
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States PCSK9 Inhibitors Market Size (Million USD) by Region (2013-2025)
Figure The West PCSK9 Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest PCSK9 Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic PCSK9 Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England PCSK9 Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US PCSK9 Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest PCSK9 Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States PCSK9 Inhibitors Sales (K Units) and Growth Rate (2013-2025)
Figure United States PCSK9 Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States PCSK9 Inhibitors Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States PCSK9 Inhibitors Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States PCSK9 Inhibitors Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States PCSK9 Inhibitors Sales Share by Players/Suppliers
Figure 2017 United States PCSK9 Inhibitors Sales Share by Players/Suppliers
Figure United States PCSK9 Inhibitors Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States PCSK9 Inhibitors Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States PCSK9 Inhibitors Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States PCSK9 Inhibitors Revenue Share by Players/Suppliers
Figure 2017 United States PCSK9 Inhibitors Revenue Share by Players/Suppliers
Table United States Market PCSK9 Inhibitors Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market PCSK9 Inhibitors Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States PCSK9 Inhibitors Market Share of Top 3 Players/Suppliers
Figure United States PCSK9 Inhibitors Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers PCSK9 Inhibitors Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers PCSK9 Inhibitors Product Category
Table United States PCSK9 Inhibitors Sales (K Units) by Region (2013-2018)
Table United States PCSK9 Inhibitors Sales Share by Region (2013-2018)
Figure United States PCSK9 Inhibitors Sales Share by Region (2013-2018)
Figure United States PCSK9 Inhibitors Sales Market Share by Region in 2017
Table United States PCSK9 Inhibitors Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States PCSK9 Inhibitors Revenue Share by Region (2013-2018)
Figure United States PCSK9 Inhibitors Revenue Market Share by Region (2013-2018)
Figure United States PCSK9 Inhibitors Revenue Market Share by Region in 2017
Table United States PCSK9 Inhibitors Price (USD/Unit) by Region (2013-2018)
Table United States PCSK9 Inhibitors Sales (K Units) by Type (2013-2018)
Table United States PCSK9 Inhibitors Sales Share by Type (2013-2018)
Figure United States PCSK9 Inhibitors Sales Share by Type (2013-2018)
Figure United States PCSK9 Inhibitors Sales Market Share by Type in 2017
Table United States PCSK9 Inhibitors Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States PCSK9 Inhibitors Revenue Share by Type (2013-2018)
Figure Revenue Market Share of PCSK9 Inhibitors by Type (2013-2018)
Figure Revenue Market Share of PCSK9 Inhibitors by Type in 2017
Table United States PCSK9 Inhibitors Price (USD/Unit) by Types (2013-2018)
Figure United States PCSK9 Inhibitors Sales Growth Rate by Type (2013-2018)
Table United States PCSK9 Inhibitors Sales (K Units) by Application (2013-2018)
Table United States PCSK9 Inhibitors Sales Market Share by Application (2013-2018)
Figure United States PCSK9 Inhibitors Sales Market Share by Application (2013-2018)
Figure United States PCSK9 Inhibitors Sales Market Share by Application in 2017
Table United States PCSK9 Inhibitors Sales Growth Rate by Application (2013-2018)
Figure United States PCSK9 Inhibitors Sales Growth Rate by Application (2013-2018)
Table Amgen Basic Information List
Table Amgen PCSK9 Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen PCSK9 Inhibitors Sales Growth Rate (2013-2018)
Figure Amgen PCSK9 Inhibitors Sales Market Share in United States (2013-2018)
Figure Amgen PCSK9 Inhibitors Revenue Market Share in United States (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly PCSK9 Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly PCSK9 Inhibitors Sales Growth Rate (2013-2018)
Figure Eli Lilly PCSK9 Inhibitors Sales Market Share in United States (2013-2018)
Figure Eli Lilly PCSK9 Inhibitors Revenue Market Share in United States (2013-2018)
Table Sanofi Basic Information List
Table Sanofi PCSK9 Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi PCSK9 Inhibitors Sales Growth Rate (2013-2018)
Figure Sanofi PCSK9 Inhibitors Sales Market Share in United States (2013-2018)
Figure Sanofi PCSK9 Inhibitors Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer PCSK9 Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer PCSK9 Inhibitors Sales Growth Rate (2013-2018)
Figure Pfizer PCSK9 Inhibitors Sales Market Share in United States (2013-2018)
Figure Pfizer PCSK9 Inhibitors Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis PCSK9 Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis PCSK9 Inhibitors Sales Growth Rate (2013-2018)
Figure Novartis PCSK9 Inhibitors Sales Market Share in United States (2013-2018)
Figure Novartis PCSK9 Inhibitors Revenue Market Share in United States (2013-2018)
Table Roche Basic Information List
Table Roche PCSK9 Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche PCSK9 Inhibitors Sales Growth Rate (2013-2018)
Figure Roche PCSK9 Inhibitors Sales Market Share in United States (2013-2018)
Figure Roche PCSK9 Inhibitors Revenue Market Share in United States (2013-2018)
Table Merck Basic Information List
Table Merck PCSK9 Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck PCSK9 Inhibitors Sales Growth Rate (2013-2018)
Figure Merck PCSK9 Inhibitors Sales Market Share in United States (2013-2018)
Figure Merck PCSK9 Inhibitors Revenue Market Share in United States (2013-2018)
Table Alnylam Basic Information List
Table Alnylam PCSK9 Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Alnylam PCSK9 Inhibitors Sales Growth Rate (2013-2018)
Figure Alnylam PCSK9 Inhibitors Sales Market Share in United States (2013-2018)
Figure Alnylam PCSK9 Inhibitors Revenue Market Share in United States (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca PCSK9 Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca PCSK9 Inhibitors Sales Growth Rate (2013-2018)
Figure AstraZeneca PCSK9 Inhibitors Sales Market Share in United States (2013-2018)
Figure AstraZeneca PCSK9 Inhibitors Revenue Market Share in United States (2013-2018)
Table Affiris Basic Information List
Table Affiris PCSK9 Inhibitors Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Affiris PCSK9 Inhibitors Sales Growth Rate (2013-2018)
Figure Affiris PCSK9 Inhibitors Sales Market Share in United States (2013-2018)
Figure Affiris PCSK9 Inhibitors Revenue Market Share in United States (2013-2018)
Table BMS Basic Information List
Table Ionis Pharmaceuticals Basic Information List
Table Cyon Therapeutics Basic Information List
Table Daiichi Sankyo Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of PCSK9 Inhibitors
Figure Manufacturing Process Analysis of PCSK9 Inhibitors
Figure PCSK9 Inhibitors Industrial Chain Analysis
Table Raw Materials Sources of PCSK9 Inhibitors Major Players/Suppliers in 2017
Table Major Buyers of PCSK9 Inhibitors
Table Distributors/Traders List
Figure United States PCSK9 Inhibitors Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States PCSK9 Inhibitors Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States PCSK9 Inhibitors Price (USD/Unit) Trend Forecast (2018-2025)
Table United States PCSK9 Inhibitors Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States PCSK9 Inhibitors Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States PCSK9 Inhibitors Sales Volume (K Units) Forecast by Type in 2025
Table United States PCSK9 Inhibitors Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States PCSK9 Inhibitors Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States PCSK9 Inhibitors Sales Volume (K Units) Forecast by Application in 2025
Table United States PCSK9 Inhibitors Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States PCSK9 Inhibitors Sales Volume Share Forecast by Region (2018-2025)
Figure United States PCSK9 Inhibitors Sales Volume Share Forecast by Region (2018-2025)
Figure United States PCSK9 Inhibitors Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...